 |
MART-1 adenoviral gene therapy for malignant melanoma |
|---|---|
| Trade Name | |
| Orphan Indication | Metastatic melanoma |
| USA Market Approval | USA |
| USA Designation Date | 1997-03-28 00:00:00 |
| Sponsor | Genzyme Corporation;500 Kendall Street;Cambridge, Massachusetts, 01701 |
| |
MART-1 adenoviral gene therapy for malignant melanoma |
|---|---|
| Trade Name | |
| Orphan Indication | Metastatic melanoma |
| USA Market Approval | USA |
| USA Designation Date | 1997-03-28 00:00:00 |
| Sponsor | Genzyme Corporation;500 Kendall Street;Cambridge, Massachusetts, 01701 |